Granting Performance-Linked Stock Options to Officers and Employees
First written in FY2022-Q1. 7 of 9 entries say "Advanced", first in FY2023-Q1. Latest entry: FY2026-H1.
- FY2026-H1AdvancedAnnual report
「Note: The increase resulted from the exercise of stock acquisition rights.」
Performance-linked stock options resulted in a 60,000-share increase through exercises during the first half of 2026. The 14th series disclosed 1,270 rights as a material change. - FY2025AdvancedAnnual report
「The stock acquisition rights are being issued for consideration to officers and employees of our group to increase their motivation and morale and further strengthen group cohesion as we seek to expand performance and corporate value over the medium term.」
During FY2025, exercise of stock acquisition rights increased common shares by 118,000, and 1,290 14th-series rights covering 129,000 shares were issued on 23 January 2026. - 2026-03-06AdvancedGeneral Meetings of Shareholders
「At a meeting of the Board of Directors held on 12 December 2025, the company resolved to issue paid stock options (the 14th series of stock acquisition rights), which were issued on 23 January 2026.」
The 14th series of stock acquisition rights, a performance-linked stock option for officers and employees, has been issued. - FY2024-H1AdvancedAnnual report
「During the interim consolidated accounting period, we recorded one-time expenses related to the acquisition of Taskforce and goodwill amortization because Taskforce became a consolidated subsidiary. In addition, because the increase in revenue from its consolidation made achievement of the exercise condition for the 11th series of stock acquisition rights granted in May 2022 more likely, we recorded share-based compensation expenses.」
The increase in revenue from consolidating Taskforce made achievement of the 11th-series exercise condition more likely, resulting in share-based compensation expense of ¥191,927 thousand. The performance-linked stock options reached the accounting expense-recognition stage. - FY2024-Q1AdvancedAnnual report
「At a board meeting held on 1 April 2024, the company resolved under Articles 236, 238 and 240 of the Companies Act to issue stock acquisition rights, referred to below as the 13th series of stock acquisition rights, to directors and employees of the company and its subsidiaries, and issued them on 19 April 2024.」
The company actually issued the 13th series of stock acquisition rights to directors and employees of the company and its subsidiaries. - FY2023AdvancedAnnual report
「The increase in common shares resulted from the exercise of stock acquisition rights.」
Exercise of stock acquisition rights increased common shares by 272,000 during 2023. The 12th series covering 100,000 shares remained outstanding, while 88,000 shares under the 11th series expired. - FY2023-Q1AdvancedAnnual report
「These stock acquisition rights were issued for consideration at ¥100 per right.」
For stock acquisition rights approved on 15 December 2022, the company issued 1,000 rights covering 100,000 shares on 31 January 2023 to 1 company employee, 2 directors of a subsidiary and 5 subsidiary employees. The exercise period is from 1 April 2027 to 30 January 2033. - FY2022-Q2AchievedAnnual report
「Note: The issuance terms as of the allotment date of the stock acquisition rights, 31 May 2022, are described.」
The company disclosed the terms of the 11th series as of 31 May 2022: 5,312 rights, 531,200 underlying shares and an exercise period from 1 April 2024 to 31 May 2032. Issuance-related expenses were also recorded, indicating that the grant had been implemented. - FY2022-Q1First statedAnnual report
「We resolved to issue stock acquisition rights, referred to below as the 11th series of stock acquisition rights, to directors, corporate auditors and employees of the company and its subsidiaries.」
The company first disclosed plans to issue 5,312 11th-series stock acquisition rights covering 531,200 shares to directors, corporate auditors and employees of the company and its subsidiaries. The exercise period is from 1 April 2024 to 31 May 2032, subject to revenue exceeding ¥3,200 million.